Arakawa, N.; Yagi, H.; Shimizu, M.; Shigeta, D.; Shimizu, A.; Nomura, S.; Takizawa, T.; Yamada, Y.
Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders. Biomolecules 2023, 13, 112.
https://doi.org/10.3390/biom13010112
AMA Style
Arakawa N, Yagi H, Shimizu M, Shigeta D, Shimizu A, Nomura S, Takizawa T, Yamada Y.
Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders. Biomolecules. 2023; 13(1):112.
https://doi.org/10.3390/biom13010112
Chicago/Turabian Style
Arakawa, Naoya, Hisako Yagi, Mariko Shimizu, Daisuke Shigeta, Akihiko Shimizu, Shigeru Nomura, Takumi Takizawa, and Yoshiyuki Yamada.
2023. "Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders" Biomolecules 13, no. 1: 112.
https://doi.org/10.3390/biom13010112
APA Style
Arakawa, N., Yagi, H., Shimizu, M., Shigeta, D., Shimizu, A., Nomura, S., Takizawa, T., & Yamada, Y.
(2023). Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders. Biomolecules, 13(1), 112.
https://doi.org/10.3390/biom13010112
